(OSV News) — A federal judge on April 7 paused Louisiana’s lawsuit challenging the U.S. Food and Drug Administration’s approval of mifepristone pending its promised safety review.
But the judge also indicated the state could continue its challenge after that review.
U.S. District Judge David Joseph in Lafayette, Louisiana, said that the state’s challenge ...